Civica plans to distribute its insulin glargine to pharmacies across the United States for $45 for a box of five pens. “Through the partnership we formed with Civica more than six years ago, BCBSA and ...
Langlara is supplied as a 3mL single-patient-use prefilled pen. The Food and Drug Administration (FDA) has approved Langlara ™ (insulin glargine-aldy), an interchangeable biosimilar to Lantus ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results